Antitrust Laws and Competition Issues in Generic Pharmaceutical Markets
Antitrust laws in generic drug markets prevent companies from blocking cheaper alternatives through pay-for-delay deals, sham patents, and product hopping. These tactics raise prices and hurt patient access. Enforcement is evolving globally, with the U.S., EU, and China taking stronger action.
Mar 19 2026